Concepedia

Publication | Open Access

Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study

37

Citations

32

References

2022

Year

Abstract

Our study confirms in a large and global population of patients with advanced HCC, not candidates for locoregional treatment the OS reported in the registration study and a high response rate with lenvatinib.

References

YearCitations

Page 1